Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM)
₹ 2612.55 -80.35 (-2.98%) Market Cap: 884.21 Bil Enterprise Value: 912.62 Bil PE Ratio: 59.16 PB Ratio: 13.18 GF Score: 96/100

Q3 2022 Torrent Pharmaceuticals Ltd Earnings Call Transcript

Jan 25, 2022 / 12:30PM GMT
Release Date Price: ₹1580.5 (+1.38%)
Operator

Ladies and gentlemen, good day And welcome to Torrent Pharma Limited Q3 FY'21 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Sudhir Menon. Thank you, and over to you, Mr. Menon.

Sudhir Menon
Torrent Pharmaceuticals Limited - Executive Director of Finance & CFO

Thank you, Nirav. Good evening, and welcome to quarter 3 FY'22 earnings call of Torrent Pharma. Very quickly, the financial performance highlights during the quarter is as follows: The revenues were INR 2,108 crores, up by 6% on Y-o-Y basis. EBITDA was at INR 585 crores, down by 5% on a Y-o-Y basis. The profit before tax was at INR 357 crores, same as a corresponding quarter in the previous year.

Net profit after tax was at INR 249 crores, which is down by 16%, essentially because of the tax change, which has happened during the year. Profitability for the quarter was impacted due to higher-than-anticipated price erosion in the U.S.-based business, coupled with under absorption of a certain amount of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot